Federated Hermes, Inc. Cv Rx, Inc. Transaction History

Federated Hermes, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$11.67 - $33.01 $37,740 - $106,754	3,234 New	3,234 $101,000
Q1 2023 May 08, 2023	SELL	$7.08 - $19.4 $21,473 - $58,840	-3,033 Reduced 98.28%	53 $0
Q4 2022 Feb 13, 2023	SELL	$8.94 - $18.35 $97,571 - $200,271	-10,914 Reduced 77.96%	3,086 $56,000
Q3 2022 Nov 14, 2022	BUY	$6.12 - $9.5 $85,680 - $133,000	14,000 New	14,000 $131,000
Q4 2021 Feb 14, 2022	SELL	$10.65 - $18.61 $85,200 - $148,880	-8,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$14.65 - $26.07 $322,300 - $573,540	-22,000 Reduced 73.33%	8,000 $132,000
Q2 2021 Aug 16, 2021	BUY	$28.0 - $28.0 $840,000 - $840,000	30,000 New	30,000 $840,000

14.4M

56.3K

41.8K

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $292M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.